Literature DB >> 7756484

Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

D H Mitchell1, T C Sorrell, A M Allworth, C H Heath, A R McGregor, K Papanaoum, M J Richards, T Gottlieb.   

Abstract

We performed a retrospective review of cases of cerebral cryptococcosis among patients admitted to 12 Australian teaching hospitals between 1985 and 1992. Of 118 cases identified, 35 occurred in immunocompetent hosts. When cases due to Cryptococcus neoformans variety neoformans were compared with those due to Cryptococcus neoformans variety gattii, we found that the latter tended to occur in healthy hosts whose residence or job was located in a rural area, and cerebral mass lesions and/or hydrocephalus and pulmonary mass lesions were more common. For a subgroup of patients with infection due to C. neoformans variety gattii, multiple enhancing lesions were observed on cerebral computed tomograms, and papilledema, high CSF and serum cryptococcal antigen titers, and a worse prognosis (despite prolonged amphotericin B therapy and intraventricular shunt insertion) were also noted. No significant difference in clinical course or outcome in terms of variety of C. neoformans was noted for patients with cryptococcal meningitis whose computed tomographic scans appeared normal on presentation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756484     DOI: 10.1093/clinids/20.3.611

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  106 in total

1.  Chronic meningitis: a diagnostic challenge highlighted in a case of cryptococcal meningoencephalitis in an apparently immunocompetent older woman.

Authors:  Chirag Patel; Ramila Rabindra; Nima Hashemi; Michael Ward; Jayamalathy Mannar Mannan
Journal:  BMJ Case Rep       Date:  2011-10-11

2.  Does the Capsule Interfere with Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Cryptococcus neoformans and Cryptococcus gattii?

Authors:  Danilo Y Thomaz; Rafaella C Grenfell; Monica S M Vidal; Mauro C Giudice; Gilda M B Del Negro; Luiz Juliano; Gil Benard; João N de Almeida Júnior
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

3.  The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis.

Authors:  Spinello Antinori; Anna Radice; Laura Galimberti; Carlo Magni; Marco Fasan; Carlo Parravicini
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  DNA typing suggests pigeon droppings as a source of pathogenic Cryptococcus neoformans serotype D.

Authors:  D Garcia-Hermoso; S Mathoulin-Pélissier; B Couprie; O Ronin; B Dupont; F Dromer
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Cryptococcal meningitis with acute psychotic confusion in a sarcoid patient.

Authors:  Jean-Louis Goeb; Virginie Leon; Géraldine Kechid
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

6.  Concurrent cryptococcal meningitis and disseminated tuberculosis occurring in an immunocompetent male.

Authors:  Marcellin Musabende; Constance Mukabatsinda; Elisabeth D Riviello; Onyema Ogbuagu
Journal:  BMJ Case Rep       Date:  2016-02-25

7.  Cryptococcus gattii genotype VGI infection in New England.

Authors:  Russell J McCulloh; Raina Phillips; John R Perfect; Edmond J Byrnes; Joseph Heitman; Elizabeth Dufort
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

8.  Cryptococcus gattii Infection Presenting as an Aggressive Lung Mass.

Authors:  Shuwei Zheng; Thuan Tong Tan; Jaime Mei Fong Chien
Journal:  Mycopathologia       Date:  2017-12-06       Impact factor: 2.574

Review 9.  Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Neena Jain; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

10.  Cryptococcosis in HIV negative patients: findings on chest radiography.

Authors:  D J Roebuck; D A Fisher; B J Currie
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.